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Abstract
Arrhythmogenic right ventricular cardiomyopathy is a hereditary, rare disease with an
increased risk for sudden cardiac death. The disease-causing mutations are located within
the desmosomal complex and the highest incidence is found in plakophilin2. However, there
are other factors playing a role for the disease progression unrelated to the genotype such
as inflammation or exercise. Competitive sports have been identified as risk factor, but the
type and extend of physical activity as cofactor for arrhythmogenesis remains under debate.
We thus studied the effect of light voluntary exercise on cardiac health in a mouse model.
Mice with a heterozygous PKP2 loss-of-function mutation were given the option to exercise
in a running wheel which was monitored 24 h/d. We analyzed structural and functional
development in vivo by echocardiography which revealed that neither the genotype nor
the exercise caused any significant structural changes. Ejection fraction and fractional short-
ening were not influenced by the genotype itself, but exercise did cause a drop in both
parameters after 8 weeks, which returned to normal after 16 weeks of training. The
electrophysiological analysis revealed that the arrhythmogenic potential was slightly higher
in heterozygous animals (50% vs 18% in wt littermates) and that an additional stressor (iso-
prenaline) did not lead to an increase of arrhythmogenic events pre run or after 8 weeks of
running but the vulnerability was increased after 16 weeks. Exercise-induced alterations in
Ca handling and contractility of isolated myocytes were mostly abolished in heterozygous
animals. No fibrofatty replacements or rearrangement of gap junctions could be observed.
Taken together we could show that light voluntary exercise can cause a transient aggrava-
tion of the mutation-induced phenotype which is abolished after long term exercise indicat-
ing a beneficial effect of long term light exercise.
Introduction
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a severe cardiac disease, leading
to right ventricular dilation with a risk for sudden cardiac death (SCD), ventricular arrhyth-
mias and syncope. Although ARVC is classified as a rare disease, it is moving into the spotlight
as it poses a great risk for SCD among young active athletes during exercise. The vast majority
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of cases can be traced back to mutations of desmosomal proteins, with plakophilin2 (PKP2)
having the highest incidence (about, 65% of mutations, [1, 2]). Diagnosis and prognosis is con-
stantly evolving and new studies help to improve the criteria system constantly [3]. In 1994,
Task Force criteria were published with a conundrum of different factors to be taken into
account such as familial history, structural, and functional data [4]. An update was published
in 2010 as the experience has uncovered potential misdiagnosis based on the original criteria
[5]. However, the experience of the last years indicates a larger involvement of the left ventricle
as opposed to the right ventricle that had been the focus previously. The combination of crite-
ria required for a definite diagnosis reveals the diversity of the disease as well as the difficulty
for risk stratification, which often relies on age, sex and the occurrence of previous adverse
events such as syncope or non-sustained tachycardia [6]. Factors other than the disease-caus-
ing mutations seem to play a crucial role for the disease progression, such as additional muta-
tions (found in 88% of cases [1]), inflammation [7], or exercise [8].
The role of competitive sports is critical for the disease progression, as it is well known that
a significant portion of SCD in athletes is caused by ARVC [9, 10]. However, the type and
extend of physical exercise that might be most detrimental for the disease progression remains
under discussion. Physical strain has been shown to increase right ventricular wall tension,
thereby contributing to acute contractile dysfunction [11] and several reports showed correla-
tions between endurance as well as highly dynamic exercise (as opposed to static exercise) and
an increased risk for arrhythmia [12–14]. On the other hand, Ruwald and colleagues found
that recreational sports, even if highly dynamic, do not increase the arrhythmogenic risk in
ARVC [15]. Up to date it remains a difficult task to decide whether recreational sports can be
permissive in asymptomatic or lightly symptomatic patients especially for young, active
patients. In 2004, the AHA released a statement suggesting only light recreational activity that
should exclude progressive elements aiming at improving performance, competitive or highly
dynamic activities, and sports that could cause injury to oneself or others [16].
Animal models have been used to study the role of exercise on adverse cardiac remodeling
without the additional predisposition of a desmosomal mutation and found that excessive
training can induce adverse structural (e.g. collagen deposition, fibrosis and eccentric hyper-
trophy) and functional (e.g. increased arrhythmogenic potential and diastolic dysfunction)
changes in the heart [17, 18]. Different models have studied the effect of physical exercise on
the disease progression in animals carrying a desmosomal mutation. One crucial point when
comparing the different outcome of these studies is the baseline condition. A homozygous
knockout mouse model of the desmosomal protein plakophilin-2 (PKP2) has been shown to
be lethal at an early embryonic state [19], while inducible homozygous knockouts show an
overt phenotype (i.e. a disrupted cellular Ca handling) already at rest, albeit without structural
changes [20]. Heterozygous PKP2 knockouts have either been described as asymptomatic or
with alterations in Ca handling [19, 21]. Variations at baseline may influence the cellular
effects of physical exercise, e.g. on eNOS signaling, and might thus influence the outcome. In
addition, the type of training plays a crucial role when studying the effects of physical activity
on the disease progression and arrhythmogenesis in ARVC models. Swimming or forced run-
ning are established models to force physical exercise simulating competitive sports but proba-
bly also pose an additional stressor for the animals and might thus influence the detected
response. Also, the total duration of exercise exposure might play a role for the outcome and
most animal studies on the effects of exercise on the disease progression have been of a shorter
duration but could nevertheless detect early changes in the right ventricular function [22].
Potentially maladaptive processes might occur only at a later stage and could be masked or
compensated for during the first weeks of training.
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The aim of this study was to test whether voluntary physical exercise, that most likely does
not add another unaccounted stressor and is more comparable to recreational sports, can
induce a phenotype in mice with a heterozygous PKP2 knock-out that is not detectable in rest-
ing animals. Such data will add to the knowledgebase about the role of exercise on the disease
onset and most importantly whether recreational sports are advisable for asymptomatic carri-
ers of desmosomal mutations.
Material and methods
All experiments were conducted according to institutional and governmental regulations for
animal use investigations conformed the directive 2010/63/EU of the European Parliament.
The study follows the Guide for the Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85–23, revised 1985) and to local institu-
tional guidelines. The study was approved by the Government of Unterfranken, Germany.
Experimental model
For this study mice harboring a heterozygous deletion of plakophilin2 (PKP2+/-) in a C57BL/
6J background [19] were bred at the central animal research facility of the University Medical
Center Regensburg and selected for the study a minimum age of 20 weeks. The animals were
housed at a 12-hour light-dark cycle and standard laboratory chow and water were provided
ad libitum. The animals were transferred into a cage with a running wheel attached, which was
equipped with a counter to track the running activity of each individual mouse. A subset of
animals was kept in standard cages without running wheels as sedentary control. The mice
were able to access the running wheel for either 8 or 16 weeks and were then sacrificed for the
final experiments.
Echocardiography
Echocardiography was performed as described before [23] at time point zero before the ani-
mals were transferred into the running or sedentary cages and again after 8 and 16 weeks of
voluntary activity or resting in the cages.
Briefly, two-dimensional M-mode echocardiography of the left ventricle (LV) was per-
formed using the Vevo 3100 Visualsonics Fujifilm MX400 imaging system (Fujifilm VisualSo-
nics Inc., Toronto, Canada). Mice were anaesthetized with 1.5–2.5% isoflurane and 97.5–
98.5% O2 via a nose cone. Heart rate was monitored to maintain comparable values between
animals of 450±50 bpm under anesthesia. The heart was imaged in the parasternal long axis
and short axis view. Digital images were analyzed with Vevo LAB 3.0.0 Software.
Electrophysiology study
The mice were anesthetized using intraperitoneal injections of medetomidine (0.5 mg/kg),
midazolam (5 mg/kg) and fentanyl (0.05 mg/kg body weight). During electrophysiology (EP)
studies the mouse body temperature was monitored by an intrarectal probe and controlled
using a mousepad circuit board equipped with a heating element (Mousepad, THM 100, Indus
Instruments, USA). All studies were performed at 37.0±0.5˚C. We used a Millar 1.1F octapolar
EP catheter (EPR-800; Millar Instruments) inserted via the right jugular vein, as previously
described [24]. A computer-based data acquisition system (Powerlab 16/35; ADI instruments)
was used to record a 1-lead body surface ECG and 4 intracardiac bipolar electrograms (Lab-
chart Pro software, version 7; AD Instruments). Right ventricular pacing was performed using
2 ms current pulses (400 mA) delivered by an external stimulator (STG-3008FA; Multi
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Channel Systems). Inducibility of ventricular arrhythmias was tested by decremental burst
pacing. Burst pacing started at a 40 ms cycle length, decreasing by 2 ms every 2 seconds to a
cycle length of 20 ms. Burst pacing was repeated one minute after the previous burst concluded
or the termination of arrhythmias. Burst pacing was performed for a total of three times in
each mouse. Ventricular arrhythmias were defined as the occurrence of rapid ventricular
potentials that occurred independent from atrial potentials and displayed altered QRS mor-
phology. Ventricular arrhythmias were considered significant if they at least occurred as trip-
lets. Burst stimulation was repeated 3 min after intraperitoneal injection of isoproterenol (2
mg/kg body weight). At the end of the experiment, mice were sacrificed by cervical dislocation,
while still under general anesthesia.
Tissue collection and cell isolation
After the electrophysiological analysis the animals were sacrificed while still under anesthesia
and the hearts quickly excised and transversely divided into three parts to be used for histologi-
cal and protein expression analysis, where the atria had been removed and discarded. One part
was snap frozen in liquid nitrogen and stored at -80˚C until the tissue was used for Western
Blot analysis, another part was embedded in glycerin-based media (Tissue-Tek, Sakura Finetek
Germany GmbH, Staufen, Germany) and frozen in liquid nitrogen and stored at –80˚C until
cryosectioning was performed. The third section was transferred into paraformaldehyde for
paraffin embedding and sectioning.
For cell isolation, mice were anaesthetized with isoflurane, and hearts quickly excised after
cervical dislocation. The hearts were mounted on a Langendorff perfusion system and retro-
gradely perfused with nominally Ca-free solution containing (in mM): 113 NaCl, 4.7 KCl, 0.6
KH2PO4, 0.6 Na2HPO4, 1.2 MgSO4, 12 NaHCO3, 10 KHCO3, 10 HEPES, 30 taurine, 10 BDM
(2,3 butanedione monoxime), 5.5 glucose, 0.032 phenol-red for 4 min (37˚C, pH 7.4). Then,
7.5 mg/ml liberase™ (Roche diagnostics, Mannheim, Germany), trypsin 0.6%, and 0.125 mM
CaCl2 were added and the hearts perfused until they became flaccid. Ventricular tissue was col-
lected in perfusion buffer containing 5% bovine calf serum, cut into small pieces, dispersed
and filtered, until no solid tissue was left. After Ca reintroduction by stepwise increasing [Ca]
from 0.1 mM to 0.8 mM, cardiomyocytes were plated on laminin coated glass coverslips. Cells
were allowed to settle and attach to the coating for 30 min at room temperature (RT) before
they were used for the experiments.
Ca-signaling and cellular contractions
All experiments were performed at RT in normal Tyrode solution (NT) containing (mM): KCl
4, NaCl 140, MgCl2 1, HEPES 5, Glucose 10 and CaCl2 2. Ca measurements were performed in
isolated, intact cardiac myocytes loaded with 2 μM Fura2-AM for 15 min on an inverted epi-
fluorescence microscope (IonOptix). Excitation at alternating wavelengths of 340/380 nm
resulted in emission that was detected with a photomultiplier at<515 nm for each excitation
wavelength. The sarcomere length was recorded with a video camera and calculated by Fourier
transformation of the intensity profile from the brightfield image. The cells were field stimu-
lated with platinum bath electrodes at 0.5 Hz to steady state before Ca and contractions were
recorded simultaneously. The data are presented as emission ratio of the alternating excitation
wavelengths 340/380 and the sarcomere length as nm.
SR Ca load was determined by rapid caffeine application (10 mM) after cells had been
paced to steady state at 0.5 Hz.
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Histology
For the analysis of fat infiltration in the cardiac tissue, cryosections were cut, mounted on glass
slides and air dried. After washing, the cells were first labelled with oil red to label the lipids
and subsequently the nuclei were labelled with hematoxylin. The slides were then recorded
with a microscope and the images analyzed using metamorph software to calculate the per-
centage of oil within the section.
The degree of fibrosis of the tissue was studied in sections from paraffin embedded tissue.
The sections were mounted on glass slides and after deparaffination and rehydration stained
with Weigert’s solution, Fuchsin and Aniline Blue. Collagen appears blue, while muscle cells
appear red. The slides were recorded on a microscope and the image analysis performed with
HistoQuest Software to calculate the percentage of collagen in the tissue sections.
A subset of paraffin sections was used for immunohistochemistry to study the distribution
of connexin 43 (Cx43) in the ventricular tissue. The sections were labelled with anti-Cx43
(1:400, Alomone Labs, Jerusalem, Israel) and Alexa488 (1:500, Invitrogen) and subsequently
analyzed with a confocal microscope. The confocal images were loaded into ImageJ and per-
centage of labeling at the intercalated disc vs. the cytosol was calculated. The clear accumula-
tion of the connexins at the ID enabled us to calculate the relative fluorescence intensity
without counterstain of the membranes and reduce loss of signal by using a long pass filter
and exclude any potential bleed through from the second channel.
Western blot
Cardiac tissue was homogenized in Tris buffer containing (in mM): 20 Tris-HCl, 200 NaCl, 20
NaF, 1 Na3VO4, 1 DTT, 1% Triton X-100 (pH 7.4), complete protease inhibitor cocktail
(Roche diagnostics, Mannheim, Germany) and phosphatase-inhibitor mixture (PhosSTOP,
Roche). Protein concentration was determined by BCA assay (Sigma-Aldrich Co., St. Louis,
MO, USA). Denatured proteins were separated on SDS-polyacrylamide gels (5–12%) and
transferred to nitrocellulose membranes (GE Health Care, Chalfont St Giles, UK). Specific
proteins were detected using RyR2 (1:10,000, Sigma-Aldrich Co., St. Louis, MO, USA), anti-
S2814 (1:3,000), anti-NCX1 (1:500, abcam plc, Cambridge, UK), anti-SERCA2a (1:20,000,
ABR Affinity BioReagents, Golden, CO, USA), anti-PLB (1:1,000, Badrilla Ltd., Leeds, UK),
anti-PT-17 (1:1,000, Badrilla Ltd., Leeds, UK), anti-PS-16 (1:1,000, Merck KGaA, Darmstadt,
Germany) and anti-GAPDH (1:30,000, Biotrend Chemikalien GmbH, Cologne, Germany)
antibodies followed by HRP-conjugated donkey anti-rabbit and sheep anti-mouse IgG anti-
bodies (GE Health Care, Chalfont St Giles, UK). Chemiluminescent detection was performed
with ImmobilonTM Western Chemiluminescent HRP Substrate (Millipore Corporation, Bil-
lerica, MA, USA). Expression levels of the proteins were normalized to GAPDH. Since the
total of all analyzed samples could not be analyzed on a single gel, we used reference samples
on both gels to normalize the data and compare the average protein expression levels.
Statistics
Data are presented as mean ± SEM. Before any statistical analysis was performed, the normal
distribution of the data analyzed was tested using the Shapiro-Wilk test. Statistical analyses
were performed according to the experimental setup, sample size and variability within the
groups. For setups where two groups are compared, an unpaired students t-test has been per-
formed, for all other data a mixed effects analysis or a two-way ANOVA with Geisser-Green-
house correction was performed. The statistical analysis of arrhythmia occurrence during
electrophysiological studies was performed by Chi-square test. P<0.05 was considered
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statistically significant. Analyses and graphs were generated using GraphPad Prism 9 Statistical
Software (GraphPad, San Diego, CA, USA).
Results
Running behavior
We monitored the voluntary running behavior of all mice with an automated wheel-attached
counter and recorded the turns of the running wheel for each mouse. The animals quickly
accepted the running wheel and used it during their wake time at night. We calculated the dis-
tance run per day (24 h) and found no difference between the wt animals and the PKP2+/-
mice. The average distance run per day during the first 8 weeks of running was 2.56 ± 0.15 km
for wildtype littermates (wt) vs. 2.34 ± 0.18 km for PKP2+/- animals (n = 49 and 50, respec-
tively; p = 0.81) and 2.49 ± 0.36 km for wt and 1.86 ± 0.27 for PKP2+/- animals during weeks
9–16 (n = 14 and 16, respectively; p = 0.47).
Functional and structural development
The echocardiographic study of the mice did not reveal any functional or structural changes
due to the heterozygous PKP2 mutation. The values for ejection fraction (EF), fractional short-
ening (FS), left ventricular inner diameter at diastole (LVID d) and at systole (LVID s) as well
as the interventricular septum thickness at diastole (IVS d) and at systole (IVS s) were the
same in both genotypes, indicating a very mild form of exercise that did not cause exercise-
induced hypertrophy (Table 1 and Fig 1A–1D).
We compared the data for each genotype individually to calculate whether there was a
time-dependent (sedentary, sed) or activity (run)-dependent shift in heart function or struc-
ture. We found no time- or running-dependent change in EF and FS in wildtype mice, how-
ever, we could detect a change in EF (from 58.1 ± 1.4% to 52 ± 2.4% after 8 weeks, p = 0.02)
which returned to normal after 16 weeks of running (56.7 ± 2.3%, p = 0.9 vs. baseline) in
PKP2+/- mice as well as in FS (from 30.8 ± 0.9% to 26.6 ± 1.5% after 8 weeks, p = 0.07) also
returning to normal after 16 weeks of running (29.5 ± 1.5%, p = 0.9 vs. baseline and p = 0.02 in
two-way ANOVA time dependent difference). Such a transient change was not observed in
the structural parameters such as LVID d/s and IVS d/s (Table 1). HW/BW was unchanged in
both genotypes (6.0 ± 0.18 mg/g in wt, n = 5, vs. 5.9 ± 0.27 mg/ in PKP2+/-, n = 6) and was not
affected by the physical activity of the animals (wt 8w run: 5.9 ± 0.34 mg/g, n = 8, vs. he 8w
run: 5.9 ± 0.35 mg/g, n = 7, and wt 16w run: 5.7 ± 0.38 mg/g, n = 6, vs. he 16w run: 5.3 ± 0.16
mg/g, n = 9).
Electrophysiology in vivo
The electrophysiological study in mice showed inducibility of arrhythmias in 18% of wildtype
mice at baseline (sed, n = 11), which was only slightly increased after 8 (n = 7) and 16 weeks
(n = 4) of running (to 29% and 25%, respectively (p = 0.605 sed vs. 8 weeks and p = 0.770 sed
vs. 16 weeks). An acute additional ISO challenge caused a slight increase of inducibility in sed-
entary mice (27% inducibility), which was further increased after 8 and 16 weeks of running to
57 and 50%, respectively (p = 0.205 sed vs. 8 weeks and p = 0.409 sed vs. 16 weeks).
In contrast to these findings, inducibility in sedentary PKP2+/- mice was increased at base-
line (50% inducibility, n = 10, p = 0.122 vs. wt sed). The number of sedentary PKP2+/- mice
showing induced arrhythmias upon ISO was unaltered compared to WT (40% inducibility,
p = 0.653). After 8 weeks of running, the inducibility was increased to 80% (n = 5, p = 0.264 vs
sed), which was numerically reduced to 60% after ISO challenge (p = 0.490 vs basal). Again,
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Table 1. Echocardiographic analysis.
Parameter (mean ± SEM) pre sed 8w sed 16w sed pre run 8w run 16w run
LVIDs WT 2.98 ± 0.15 2.91 ± 0.42 3.18 ± 0.09 3.10 ± 0.07 3.15 ± 0,06 3.06 ± 0.12
n = 11 n = 7 n = 6 n = 25 n = 17 n = 11
LVIDs HE 3.40 ± 0.24 3.19 ± 0.11 3.16 ± 0.11 2.94 ± 0.07 3.14 ± 0.13 2.99 ± 0.07
n = 7 n = 7 n = 6 n = 28 n = 16 n = 10
LVIDd WT 4.08 ± 0.11 4.0 ± 0.08 4.18 ± 0.12 4.08 ± 0.06 4.02 ± 0.05 4.04 ± 0.11
n = 10 n = 7 n = 6 n = 25 n = 17 n = 11
LVIDd HE 4.40 ± 0.19 4.09 ± 0.14 4.12 ± 0.11 4.09 ± 0.05 4.06 ± 0.09 4.03 ± 0.09
n = 7 n = 7 n = 6 n = 28 n = 16 n = 10
IVSs WT 1.41 ± 0.09 1.45 ± 0.03 1.43 ± 0.07 1.48 ± 0.04 1.38 ± 0.04 1.41 ± 0.05
n = 11 n = 7 n = 6 n = 27 n = 17 n = 10
IVSs HE 1.37 ± 0.09 1.20 ± 0,05 1.45 ± 0.07 1.43 ± 0.03 1.52 ± 0.04 1.49 ± 0.06
n = 7 n = 7 n = 6 n = 29 n = 17 n = 9
IVSd WT 0.95 ± 0.05 1.03 ± 0.04 1.05 ± 0.04 1.07 ± 0.03 1.07 ± 0.02 1.06 ± 0.04
n = 10 n = 7 n = 6 n = 27 n = 18 n = 10
IVSd HE 0.98 ± 0.08 0.86 ± 0.03 1.04 ± 0.05 1.06 ± 0.03 1.12 ± 0.04 1.09 ± 0.04
n = 7 n = 7 n = 6 n = 28 n = 18 n = 10
LVIDs = left ventricular inner diameter at systole; LVIDd = left ventricular inner diameter at diastole; IVSs = interventricular septum thickness at systole;
IVSd = interventricular septum thickness at diastole.
https://doi.org/10.1371/journal.pone.0252649.t001
Fig 1. Echocardiographic evaluation of PKP2 mice during 16 weeks of physical activity. Exemplary echocardiographic original traces from mice
recorded pre run/sed (A), after 8 weeks of running (B) and after 16 weeks of running (C). There was no difference between the genotypes at baseline in the
functional characteristics ejection fraction (EF) and fractional shortening (FS) (D). Heterozygous PKP2 mice (he) showed a reduction in EF after 8 weeks of
running, which was normalized after 16 weeks (E). Heterozygous animals also showed a reduction in FS after 8 weeks of running which normalized again
at 16 weeks (F).
https://doi.org/10.1371/journal.pone.0252649.g001
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this drop might in part be due to the lower number of animals studied after 8 weeks of running
compared to the sedentary animals. Surprisingly, after 16 weeks of running, only 17% of
PKP2+/- mice (n = 6) had inducible arrhythmias, which was increased to 67% by ISO
(p = 0.079 vs. basal; Fig 2A).
To evaluate potential mechanisms leading to a higher propensity for arrhythmias in
PKP2+/- mice at rest, we measured the protein levels of β1-adrenergic receptor (β1-AR).
β1-ARs regulate contractility and PKA-mediated effects on various signaling proteins in car-
diac myocytes but can cause detrimental effects when stimulated chronically [25]. The relative
protein level of the β1- AR was markedly higher in PKP2+/- mice compared to their wt
Fig 2. Electrophysiological in vivo study of mice after long-term training. (A) The electrophysiological study revealed that long-term training in mice
did not cause an increased vulnerability in wt mice under basal conditions (18% in sedentary animals, n = 11 vs. 29% after 8 weeks, n = 7 and 25% after 16
weeks of running, n = 4). An additional ISO challenge did cause a slightly increased occurrence of arrhythmia in sedentary mice from 18% at basal
conditions to 27% under ISO, which was increased to 57% under ISO after 8 weeks of training. This vulnerability was reduced after 16 weeks of training to
50%. The heterozygous animals showed increased occurrence of arrhythmia under basal conditions in sedentary mice of 50% (n = 10), which even
increased after 8 weeks of training (80%; n = 5), but was reduced to only 17% after 16 weeks of training (n = 6). Interestingly the additional ISO challenge
did not cause an increase of arrhythmia in heterozygous animals at rest or after 16 weeks of training. After 8 weeks of training the rate of arrhythmia
observed dropped slightly. B Protein expression levels of β1-adrenergic receptor in cardiac tissue of wt mice was unaffected by voluntary running but was
significantly lower compared to PKP2+/- mice (0.942 ± 0.113 vs. 3.229 ± 0.609, respectively; p = 0.0181). C representative traces from wt sedentary mice
under basal conditions without arrhythmia and D from PKP2+/- sedentary mice under basal conditions displaying arrhythmia after burst stimulation.
https://doi.org/10.1371/journal.pone.0252649.g002
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littermates (3.23 ± 0.61 vs. 0.94 ± 0.11, p = 0.018; Fig 2B), however, there was a greater scatter
within the tested PKP2+/- mice. The protein level was unaffected by voluntary running in both
genotypes with a slight decrease in the PKP2+/- mice.
Cellular Ca-handling and contractility
To test whether abnormal cellular Ca cycling could explain some of the changes observed in
functional alterations, we analyzed cellular Ca handling in isolated cardiac myocytes and
found slight time-dependent alterations after long-term activity in PKP2+/- mice.
We analyzed CaT in cells loaded with Fura2 and found that the cells from wildtype animals
developed an increased diastolic Ca concentration after 16 weeks of physical activity, which
also translated into a significantly enlarged peak Ca release from the SR during each cardiac
cycle (Fig 3A and 3D). While this enlarged CaT amplitude was also observed in cells from
PKP2+/- mice after 16 weeks of training, an increased diastolic cytosolic Ca concentration
could not be observed. It has to be noted that baseline values for diastolic and systolic Ca con-
centration as well as the time course before training were equal between the different geno-
types. Interestingly, the CaT duration (CaTD), a well-established factor influencing the
propensity for arrhythmias [23, 26] showed small but distinct differences between the geno-
types. CaT rise time was markedly faster after 16 weeks of training, indicating a potential adap-
tation to the physical activity and related higher demand. A similar shift could not be detected
in the cells from the PKP2+/- mice (Fig 3B). In contrast, the decay times were not affected in
wildtype animals, where the times remained constant even after 16 weeks of physical activity.
The PKP2+/- mice instead showed a markedly fastened decay rate after 8 weeks of training
(contrary to the rise time) which returned to initial values after 16 weeks (Fig 3C). Taken
together, wt animals showed shortened CaTD after 16 weeks of voluntary training (p = 0.018
vs. baseline) which could not be observed in PKP2+/- mice which had a transient CaTD short-
ening after 8 weeks of training (p = 0.022 vs. baseline). SR Ca content showed a tendency
towards higher content after 16 weeks of training in wildtype animals, albeit not statistically
significant. This change was not observed in PKP2+/- mice where SR Ca content remained
constant (Fig 3E). The calculated fractional release (FR) from these mean data indicates a
higher FR after 16 weeks of training in both wt and PKP2+/- animals.
The cellular contractility is impaired in PKP2+/- mice after long term activity with a time
dependent development. The contractility of cardiac myocytes is directly affected by the Ca
cycling, as Ca acts as the main second messenger between cardiac excitation and the actual
contraction [27]. We recorded the sarcomere shortening after electrical stimulation to have a
measure of the contractility of the single cells. Despite the increased diastolic Ca concentration
in wildtype cells after 16 weeks of training, we found a longer sarcomere length compared to
the initial values, indicating a stronger relaxation during diastole (Fig 3F). This was also seen
as a trend in PKP2+/- mice (p = 0.075). Interestingly, the maximal shortening in wildtype cells
was not increased in wildtype cells even though the systolic Ca was higher after 16 weeks of
training (albeit a trend towards higher values was detected). In contrast, the PKP2+/- cells
showed a larger contraction after 16 weeks of training, in accordance with the systolic Ca (Fig
3G). The time until the maximal contraction was reached was significantly faster after 16
weeks of training in wildtype but not PKP2+/- cells (Fig 3H). We were however surprised to
find a distinct fastening of the relaxation time after 16 weeks of training in wildtype mice,
which was not visible in the CaTs. The PKP2+/- cells had a quicker relaxation after 8 weeks,
which was not maintained after 16 weeks of training (Fig 3I).
Histology. Fibro-fatty replacements are often found in ARVC patients during disease pro-
gression [28, 29], we thus studied the composition of cardiac tissue slices from sedentary and
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Fig 3. Cellular Ca cycling and contractions after long-term training. Fura-2 loaded cardiac myocytes were electrically stimulated and CaT measured. The
CaT amplitude significantly increased after 16 weeks of training in both genotypes with p<0.0001 (A). While the CaT rise time was significantly faster in
cells from wt mice after 16 weeks training, this trend was already significant in cells from the PKP2+/- animals after 8 weeks (B). However, the decay time to
reach 50% of the maximal amplitude did change significantly in wt mice during 8 weeks of training (p = 0.04), while the PKP2+/- mice showed a significant
(p = 0.001) acceleration after 8 weeks of running that was abolished again after 16 weeks (C). Diastolic Ca values did not change in PKP2+/- mice during the
course of training after 8 and 16 weeks, but the wt had a distinct increase in diastolic Ca values after 16 weeks of training (p = 0.004) (D). Conversely, the SR
Ca load measured by caffeine application, was unchanged in PKP2+/- mice and in wt animals (E). In parallel to the fluorescent measurement of cytosolic Ca,
we recorded the contractility by measuring the sarcomere length with a bright field video camera system. The diastolic sarcomere length was longer after 16
weeks of training in wt animals (p = 0.008), albeit the diastolic Ca levels were increased (F). In accordance to the CaT amplitudes, the maximal shortening
of the cells is significantly increased in PKP2+/- mice after 16 weeks of training (p = 0.0023), however this translation was not observed in wt animals were
only a slight but non-significant increase was seen (G). Time to maximal shortening was significantly faster in wt mice after 8 (p = 0.03) and 16 weeks of
training (p = 0.05) and in PKP2+/- animals, as seen in Ca kinetics (H). The time to 50% relaxation, was significantly faster after 8 weeks of training in
PKP2+/- mice (p = 0.006) but not after 16 weeks (I). All data are shown as single cell data points from different animals: wt sed: 4 animals, wt 8 weeks: 6
animals, wt 16 weeks: 3 animals, hw sed: 4 animals, PKP2+/- 8 weeks: 5 animals and PKP2+/- 16 weeks: 2 animals).
https://doi.org/10.1371/journal.pone.0252649.g003
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running mice. The histological analysis of cardiac tissue sections taken from the transverse
plane did not show an increased amount of fibrosis after long-term training in PKP2+/- mice.
Ventricular slices were stained with Tri-Chrome-Masson to analyze the relative amount of
fibrosis in each slice. We could not observe a discernable difference between the genotypes
and the long-term physical activity did not cause an in- or decrease in fibrosis in neither the
wildtype nor the PKP2+/- mice. Furthermore, we could not detect any differences between the
left and right ventricular areas (Fig 4A).
Moreover, the oil red staining did not reveal a significant increase in fatty replacement in
the cardiac tissue due to the physical activity. However, we found a higher degree of fatty infil-
tration in the PKP2+/- mice at baseline condition before running in comparison to the wildtype
animals (7.6 ± 0.57% vs. 5.8 ± 0.50%; p = 0.039, unpaired t-test; Fig 4B).
Since gap junctions are linked to the desmosomes through PKP2 [30], we analyzed the
localization of the building blocks of gap junctions, Cx43, in the cells to understand whether a
mislocalization could cause a potential loss of functional channels at the intercalated disc (ID).
When calculating the amount of Cx43 labeling at the ID relative to the cytosolic localization,
we found no shift of Cx43 away from the intercalated discs (ID) after long-term training or
due to the genotype (Fig 4C). To verify that the Cx43 was indeed localized at the intercalated
disc, we performed double labeling of the slices with N-cadherin, which is a specific marker
for the IDs and found a high overlap of both labels (S3 Fig in S1 File).
Protein expression
To test whether changes on the protein level might be the underlying cause for the functional
changes we observed on the cellular level (or lack of thereof in HE mice such as CaTD shorten-
ing, diastolic Ca levels) we performed extensive Western Blot analyses. First, we compared the
protein expression levels of ECC key players at baseline without physical activity in the two dif-
ferent genotypes. We found that the analyzed proteins were not changed due to genotype
(RyR, SERCA, PLB, NCX as well as the phosphorylation of RyR at S2814 and PLB at pS-16 and
pT-17; S2 Fig in S1 File), except the PKA-mediated phosphorylation of the RyR at S2030,
which was significantly increased in he mice (p = 0.008; Fig 5C). To get a better understanding
of molecular changes that might occur during long-term training, we compared the protein
levels of ECC key players after 8 and 16 weeks of running. We found that RyR protein level in
wt mice or in PKP2+/- mice after 8 and 16 weeks (Fig 5A) and the phosphorylation of the RyR
by CaMKII at Ser2814, as often found during hypertrophic signaling, was not affected by train-
ing (Fig 5B). This indicates that the altered diastolic Ca level in wt mice after training could
not be accounted to the protein level or CaMKII-dependent regulation of the Ca release chan-
nel. However, we found higher PKA-mediated phosphorylation of the RyR at S2030 in
PKP2+/- mice, which remained unaltered after 8 or 16 weeks of running (Fig 5C). We then
measured the protein level of the Na-Ca-exchanger NCX and again found no shift due to the
training in both genotypes, indicating that the NCX protein level does not play a role in the
observed changes in Ca cycling (esp. Ca removal; Fig 5D). However, the SERCA protein level
showed a trend towards higher protein levels in wt mice after 16 weeks of training, which
might explain the slightly increased SR Ca content seen in wt mice (Figs 3E and 5E). Interest-
ingly, total PLB protein level was unchanged in wt mice during training, but was significantly
reduced in PKP2+/- mice after 16 weeks of training, pointing towards a shift in SERCA regula-
tion (Fig 5F). Similarly, the phosphorylation of PLB by PKA at Ser16 and CaMKII at Thr17
was significantly increased after 8 weeks of training, however, in both cases the phosphoryla-
tion level was partially reduced after 16 weeks of training (Fig 5G and 5H).
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Fig 4. Histological analysis of cardiac tissue after long-term training. (A) Representative images for sedentary, 8 weeks of running and 16 weeks of
running tissue from wt (upper row) and PKP2+/- mice (lower row) are shown for Trichrome-stained ventricular slices. No change of fibrous tissue could be
detected in either genotype or in response to long-term training. (B) The oil stain in frozen sections from cardiac tissue with oil red did not reveal an
increase in fatty replacements. (C) We labeled the gap junctions with a Cx43 specific antibody and analyzed the images by confocal microscopy. The
connexins were predominantly located at the intercalated discs as seen in the representative images shown. There was no shift in subcellular distribution
due to genotype or long-term training observed. The single data points indicate the number of animals analyzed.
https://doi.org/10.1371/journal.pone.0252649.g004
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Fig 5. Protein expression levels of ECC key players. We analyzed the protein expression levels by Western Blot to reveal the potential changes underlying
the functional alterations we have found in cells from wt and PKP2+/- mice with and without training. First, we analyzed the RYR2 protein levels and found
no changes neither between the genotypes nor due to training (A). In addition, the phosphorylation of the RyR by CaMKII at S2814 is not affected (B) but
the PKA mediated phosphorylation at S2030 is higher in PKP2+/- animals but unaffected by training (C), indicating that the Ca release from the store is
unaffected by physical activity. The protein level of the Na-Ca-exchanger NCX is also unchanged and thus most likely does not play a significant role in
shifted Ca removal processes (D). In accordance with the SR-Ca load data, we found a slight shift towards higher expression of SERCA protein in wt
animals after 16 weeks of training, albeit not significant (E). The overall PLB protein level as well as the PLB-phosphorylation was unchanged in wt animals
(F-H), whereas the PLB protein level was significantly reduced in PKP2+/- animals after 16 weeks (p = 0.001) of training. In addition to the protein levels of
PLB, the phosphorylation by PKA at Ser16 was significantly increased after 16 weeks of training (p = 0.007) in PKP2+/- mice compared to wt mice after 16
weeks (G). A similar pattern was found at the phosphorylation site for CaMKII, Thr17, which was significantly increased as well (p = 0.03) after 16 weeks,
as well as in comparison to wt animals after 16 weeks (p = 0.03) (H).
https://doi.org/10.1371/journal.pone.0252649.g005
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Discussion
ARVC is a hereditary disease with its disease-causing mutations mostly located in desmosomal
proteins of which PKP2 has the highest incidence [2] among all identified ARVC cases. How-
ever, risk stratification remains difficult, and often includes previous cardiac events such as
recent syncope or non-sustained VT [6] and thus is not useful for family members that are
asymptomatic at the time of diagnosis. In fact, 88% of diagnosed ARVC patients have multiple
mutations [1] and exercise is considered a major environmental factor influencing the disease
progression of ARVC. To date there is no consensus on permissible exercise for ARVC
patients and their family members and results are contradictory [31] where some groups
found that endurance exercises increase the disease severity [13] and others report that only
sports with a highly dynamic component, increasing oxygen uptake by more than 70% is detri-
mental [14, 32]. Ruwald et al. [15] on the contrary found that recreational sports, even highly
dynamic, do not increase the arrhythmogenic risk while Mazzanti et al. [33] report an
increased risk already at fairly modest levels of exercise. These contradictory findings and the
importance of treatment guidelines for patients and asymptomatic family members alike call
for controlled studies on the subject.
There are various animal models available to mimic ARVC with and without physical exer-
cise [34]. Specific mouse models with a PKP2 mutation have shown that a homozygous knock-
out of PKP2 is lethal at an embryonic stage [19] and the heterozygous mutation does not
develop overt structural alterations [21]. In fact, we could confirm a lack of overt structural
changes in the mouse model at rest and did not find an increased arrhythmogenic potential in
vivo as seen in our electrophysiological study. In addition, structural and functional in vivo
data did not show any signs of deterioration in sedentary mice and also in vitro we could not
find any alterations in function as measured by Ca handling and contractility as well as protein
expression or structure of the cardiac tissue. This is in line with the notion that not all patients
carrying a PKP2 mutation develop symptoms and, as elaborated above, additional triggers
may be needed to induce arrhythmogenic disease progression.
Although inducible homozygous mutations of PKP2 do induce pathogenic alterations in a
mouse model [20, 35] they might not reflect the situation in patients properly. Exercise models
are needed to understand the influence of exercise on disease progression and several groups
have tested different models in the past carrying plakoglobin or desmoplakin mutations [34]
but also an AAV-induced PKP2 knockout model that has been exercised has been described
[36]. Recently, a heterozygous PKP2 knockout mouse was exercised on a treadmill and the
effects on in vivo and in vitro structure and function have been described [37]. They could not
find an exaggerated phenotype after physical exercise as measured by protein expression levels
of key players such as CaV1.2 or AnkB or fibro fatty deposits in the heart tissue. They did
instead detect a slowed conduction velocity in the right ventricle and an increased susceptibil-
ity for VT ex vivo.
However, all these exercise models use different approaches and often include additional
stressors such as electric shocks or forced swimming, of which both may cause additional stress
that might exacerbate the phenotype described. Also, the duration of endurance training
might play a critical role, we thus decided to expose our animals to 8 and 16 weeks of voluntary
exercise. Even after 16 weeks of training, we could not observe any structural changes by echo-
cardiography nor by histological techniques. We speculate that this form of exercise might
mimic light leisure exercise.
The lack of fibro fatty replacements or relocation of Cx43 even after 16 weeks of training is
in line with the finding that PKP2-induced electropathy can occur independent of structural
perturbations but might still be causative for SCD in patients [38]. Although fibrofatty
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replacements are often found in ARVC patients this is not an exclusive trait to the disease. It
has to be noted that we monitored left ventricular structure and function and might thus have
missed early changes of the right ventricle.
However, we did see a mildly reduced ejection fraction and fractional shortening in PKP2
mice after 8 weeks of training. Interestingly, this reduction was abolished after 16 weeks of
training. We speculate that the animals were able to adapt to the light exercise regimen after an
initial period of maladaptation. This would point towards a beneficial effect of light voluntary
training on cardiac function in predisposed animals in the long term. The lack of structural
alterations in conjunction with functional changes can also be seen in ARVC patients with a
PKP2 mutation who do not necessarily show structural alterations when electropathy develops
[38]. Furthermore some reports indicate a risk reduction due to regular physical activity [39].
On a cellular level we observed complex changes in Ca handling that are not easy to link to
pro-arrhythmic activity. Despite unchanged SR load, we observed a significant increase in Ca
transient amplitude for both trained WT and trained mice with heterozygous PKP2 loss-of-
function. Interestingly, the Ca rise time was also significantly faster for both trained genotypes
indicating that training stimulated coupled-gating from LTCC to RyR2 by either increased
LTCC or enhanced fractional RyR2 release. We have evidence for the latter, since calculated
fractional release was increased after 16 weeks of training in both wt and PKP2+/- animals.
The effects of training on diastolic function are even more complex but may include an
enhancement of SERCA function and increased diastolic SR Ca leak. We did not measure the
latter parameter directly, but it can be inferred from the Ca transient kinetics and SR Ca load
data. Interestingly, this training effect on diastolic Ca handling was substantially different
between WT and PKP2+/- animals: While enhanced SR Ca leak in WT with moderate stimula-
tion of SERCA may have resulted in increased diastolic Ca concentration at least after 16
weeks of running, a more pronounced stimulation of SERCA in PKP2+/- animals may have
prevented the increase in diastolic Ca.
Our data stand in contrast to recent findings by van Opbergen et al. [37], who could detect
changes due to voluntary exercise as soon as 4 weeks after the onset of training. However it has
to be pointed out, that their animal model already had distinct changes at rest, which we could
not detect. Also, it is unclear whether the functional changes presented after training in the
aforementioned study can be solely attributed to the exercise regimen or might in fact be
caused by the genotype itself. The alterations we found on the protein level cannot fully explain
the changes in Ca handling. Interestingly, we found a significantly increased PKA-mediated
RyR2 phosphorylation at S2030, a phosphorylation site that is crucial for a complete and ade-
quate β-adrenergic response in cardiac myocytes [40]. A recent report by Wang et al. [41]
found that this site is hyperphosphorylated in left ventricular tissue of ARVC patients and they
went on to show that a S2030 hyperphosphorylation causes DADs and spontaneous Ca release
in a mouse model. Follow up studies will be necessary to understand the role of the L-type Ca
channels in our model as altered Ca currents might give an explanation for the changes we see
in CaT amplitude. Localization and number of RyRs within a couplon might also influence the
amount of Ca release from the SR during a twitch.
In order to understand the actual effect of physical exercise on arrhythmogenity, we per-
formed electrophysiological studies in vivo. These studies led to two interesting findings: first
in wt animals the arrythmogenic potential under baseline conditions is unaffected by long-
term training. However, an additional ISO challenge increased the risk in trained animals,
which becomes detectable already after 8 weeks and is partially reduced after another 8 weeks
of training. A study on rats could show that long term training could induce arrhythmogenic
events, even though their training model potentially added an additional stressor as the tread-
mill running was forced [17]. In contrast, we found an increased propensity towards
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arrhythmia in PKP2+/- mice already at baseline, which is in line with our finding of increased
β-AR protein expression in PKP2+/-. Here, the long-term running of 16 weeks seemed to be
even beneficial as the rate of adverse events dropped.
There was a highly interesting discovery when we tested for arrhythmia under β-adrenergic
stimulation. In contrast to the control animals, the PKP2+/- mice did not react at all to the
additional stressor, even though the β-AR protein levels remained high in our animals. In con-
trast to these findings are data from a subset of ARVC patients who have significantly downre-
gulated myocardial β-adrenergic receptors [42, 43]. This discrepancy might be explained by an
uncoupling from GS due to the physical exercise, similar to findings in heart failure [44–46]. In
addition, an increase in Gα might be antagonizing the β-adrenergic signaling in these mice
[47–49]. However, the ability to respond to stress by positive inotropy is crucial for a proper
stress response and a lack thereof can cause a severely aberrant cardiac phenotype as seen in
chronic heart failure [25, 27]. We speculate that the altered response to β-adrenergic signaling
might not be caused by the signal itself but more likely by changes in receptor expression and
the responsiveness of the RyRs. As discussed above, the hyperphosphrylation at S2030 might
be one if not the reason for a reduced responsiveness.
The shift in protein expression that is overt in PLB expression and the highly increased
phosphorylation of the almost diminished PLB protein that is left after 8 weeks of training
might be indicative of an effort to counterbalance the reduced ability to properly respond to
beta adrenergic stimulation. However, further studies will have to be performed to prove this
theory, especially since these changes are not clearly reflected in the functional data.
Taken together, our data indicate that low intensity workout does not cause an increase of
sudden cardiac death and overt arrhythmia in a mouse model and seems to be even beneficial
during an early, transient phase. The inability to respond to β-adrenergic stimuli is indicative
for an early phenotype during ARVC disease progression. This model might be useful to shed
light on the benefits of light, recreational training for ARVC patients and their family members
with no or light symptoms. We conclude that recreational exercise in a mouse model might
even be protective and thus a closer look at exercise behavior in asymptomatic or lightly symp-
tomatic mutation carriers might be useful to improve the risk assessment and training guide-
lines for ARVC patients and their family members. Future studies will have to focus on the
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riela Pietrzyk and Veronika Mühl for their assistance preparing tissue slides and Sebastian
Benkhoff for the EP assistance.
Author Contributions
Conceptualization: Karin P. Hammer, Stefan Wagner, Lars S. Maier.
PLOS ONE PKP2 running mouse model
PLOS ONE | https://doi.org/10.1371/journal.pone.0252649 June 4, 2021 16 / 20
Data curation: Karin P. Hammer, Julian Mustroph, Teresa Stauber.
Formal analysis: Karin P. Hammer, Julian Mustroph, Teresa Stauber, Stefan Wagner.
Funding acquisition: Karin P. Hammer, Julian Mustroph, Stefan Wagner, Lars S. Maier.
Investigation: Karin P. Hammer, Julian Mustroph, Teresa Stauber.
Methodology: Karin P. Hammer, Julian Mustroph, Teresa Stauber.
Project administration: Karin P. Hammer.
Resources: Walter Birchmeier, Lars S. Maier.
Supervision: Karin P. Hammer, Lars S. Maier.
Writing – original draft: Karin P. Hammer.
Writing – review & editing: Karin P. Hammer, Julian Mustroph, Walter Birchmeier, Stefan
Wagner, Lars S. Maier.
References
1. Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C, et al. Clinical Presentation,
Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomy-
opathy Patients and Family Members. Circ Cardiovasc Genet. 2015; 8(3):437–46. https://doi.org/10.
1161/CIRCGENETICS.114.001003 PMID: 25820315
2. Ohno S. The genetic background of arrhythmogenic right ventricular cardiomyopathy. J Arrhythm.
2016; 32(5):398–403. https://doi.org/10.1016/j.joa.2016.01.006 PMID: 27761164
3. Corrado D, van Tintelen PJ, McKenna WJ, Hauer RNW, Anastastakis A, Asimaki A, et al. Arrhythmo-
genic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diag-
nosis. Eur Heart J. 2020; 41(14):1414–29. https://doi.org/10.1093/eurheartj/ehz669 PMID: 31637441
4. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, et al. Diagnosis of
arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocar-
dial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Car-
diomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994; 71(3):215–8.
https://doi.org/10.1136/hrt.71.3.215 PMID: 8142187
5. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmo-
genic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur
Heart J. 2010; 31(7):806–14. https://doi.org/10.1093/eurheartj/ehq025 PMID: 20172912
6. Cadrin-Tourigny J, Bosman LP, Nozza A, Wang W, Tadros R, Bhonsale A, et al. A new prediction
model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J.
2019; 40(23):1850–8. https://doi.org/10.1093/eurheartj/ehz103 PMID: 30915475
7. Lubos N, van der Gaag S, Gercek M, Kant S, Leube RE, Krusche CA. Inflammation shapes pathogene-
sis of murine arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2020; 115(4):42. https://doi.org/10.
1007/s00395-020-0803-5 PMID: 32529556
8. Prior D, La Gerche A. Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy. Heart Lung
Circ. 2020; 29(4):547–55. https://doi.org/10.1016/j.hlc.2019.12.007 PMID: 31964580
9. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young ath-
letes. N Engl J Med. 1998; 339(6):364–9. https://doi.org/10.1056/NEJM199808063390602 PMID:
9691102
10. Corrado D, Fontaine G, Marcus FI, McKenna WJ, Nava A, Thiene G, et al. Arrhythmogenic right ventric-
ular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic
Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Dis-
ease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomy-
opathies of the World Heart Federation. Circulation. 2000; 101(11):E101–6. https://doi.org/10.1161/01.
cir.101.11.e101 PMID: 10725299
11. La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, et al. Exercise-induced right ven-
tricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012; 33(8):998–
1006. https://doi.org/10.1093/eurheartj/ehr397 PMID: 22160404
12. Te Riele A, James CA, Sawant AC, Bhonsale A, Groeneweg JA, Mast TP, et al. Arrhythmogenic Right
Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population: Clinical Characterization and
PLOS ONE PKP2 running mouse model
PLOS ONE | https://doi.org/10.1371/journal.pone.0252649 June 4, 2021 17 / 20
Comparison With Adult-Onset Disease. JACC Clin Electrophysiol. 2015; 1(6):551–60. https://doi.org/
10.1016/j.jacep.2015.08.004 PMID: 29759408
13. James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, et al. Exercise increases age-
related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-
associated desmosomal mutation carriers. J Am Coll Cardiol. 2013; 62(14):1290–7. https://doi.org/10.
1016/j.jacc.2013.06.033 PMID: 23871885
14. Mitchell JH, Haskell W, Snell P, Van Camp SP. Task Force 8: classification of sports. J Am Coll Cardiol.
2005; 45(8):1364–7. https://doi.org/10.1016/j.jacc.2005.02.015 PMID: 15837288
15. Ruwald AC, Marcus F, Estes NA 3rd, Link M, McNitt S, Polonsky B, et al. Association of competitive
and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular
cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventric-
ular cardiomyopathy. Eur Heart J. 2015; 36(27):1735–43. https://doi.org/10.1093/eurheartj/ehv110
PMID: 25896080
16. Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Luna A, Corrado D, Crosson JE, et al. Recommen-
dations for physical activity and recreational sports participation for young patients with genetic cardio-
vascular diseases. Circulation. 2004; 109(22):2807–16. https://doi.org/10.1161/01.CIR.0000128363.
85581.E1 PMID: 15184297
17. Benito B, Gay-Jordi G, Serrano-Mollar A, Guasch E, Shi Y, Tardif JC, et al. Cardiac arrhythmogenic
remodeling in a rat model of long-term intensive exercise training. Circulation. 2011; 123(1):13–22.
https://doi.org/10.1161/CIRCULATIONAHA.110.938282 PMID: 21173356
18. Chang Y, Yu T, Yang H, Peng Z. Exhaustive exercise-induced cardiac conduction system injury and
changes of cTnT and Cx43. Int J Sports Med. 2015; 36(1):1–8. https://doi.org/10.1055/s-0034-1384545
PMID: 25254896
19. Grossmann KS, Grund C, Huelsken J, Behrend M, Erdmann B, Franke WW, et al. Requirement of pla-
kophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol. 2004; 167(1):149–60.
https://doi.org/10.1083/jcb.200402096 PMID: 15479741
20. Cerrone M, Montnach J, Lin X, Zhao YT, Zhang M, Agullo-Pascual E, et al. Plakophilin-2 is required for
transcription of genes that control calcium cycling and cardiac rhythm. Nat Commun. 2017; 8(1):106.
https://doi.org/10.1038/s41467-017-00127-0 PMID: 28740174
21. Cerrone M, Noorman M, Lin X, Chkourko H, Liang FX, van der Nagel R, et al. Sodium current deficit
and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency. Cardiovasc Res. 2012; 95
(4):460–8. https://doi.org/10.1093/cvr/cvs218 PMID: 22764151
22. Fabritz L, Hoogendijk MG, Scicluna BP, van Amersfoorth SC, Fortmueller L, Wolf S, et al. Load-reduc-
ing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-
deficient mice. J Am Coll Cardiol. 2011; 57(6):740–50. https://doi.org/10.1016/j.jacc.2010.09.046
PMID: 21292134
23. Beuckelmann DJ, Erdmann E. Ca(2+)-currents and intracellular [Ca2+]i-transients in single ventricular
myocytes isolated from terminally failing human myocardium. Basic Res Cardiol. 1992; 87 Suppl
1:235–43. https://doi.org/10.1007/978-3-642-72474-9_19 PMID: 1497571
24. Pabel S, Mustroph J, Stehle T, Lebek S, Dybkova N, Keyser A, et al. Dantrolene reduces CaMKIIdel-
taC-mediated atrial arrhythmias. Europace. 2020. https://doi.org/10.1093/europace/euaa079 PMID:
32413138
25. de Lucia C, Eguchi A, Koch WJ. New Insights in Cardiac beta-Adrenergic Signaling During Heart
Failure and Aging. Front Pharmacol. 2018; 9:904. https://doi.org/10.3389/fphar.2018.00904 PMID:
30147654
26. Lou Q, Fedorov VV, Glukhov AV, Moazami N, Fast VG, Efimov IR. Transmural heterogeneity and
remodeling of ventricular excitation-contraction coupling in human heart failure. Circulation. 2011; 123
(17):1881–90. https://doi.org/10.1161/CIRCULATIONAHA.110.989707 PMID: 21502574
27. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force: Springer; 2008. 427 p.
28. Romero J, Mejia-Lopez E, Manrique C, Lucariello R. Arrhythmogenic Right Ventricular Cardiomyopathy
(ARVC/D): A Systematic Literature Review. Clin Med Insights Cardiol. 2013; 7:97–114. https://doi.org/
10.4137/CMC.S10940 PMID: 23761986
29. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinico-
pathologic correlations in 22 cases. Am J Med. 1990; 89(5):588–96. https://doi.org/10.1016/0002-9343
(90)90176-e PMID: 2239978
30. Sato PY, Coombs W, Lin X, Nekrasova O, Green KJ, Isom LL, et al. Interactions between ankyrin-G,
Plakophilin-2, and Connexin43 at the cardiac intercalated disc. Circ Res. 2011; 109(2):193–201. https://
doi.org/10.1161/CIRCRESAHA.111.247023 PMID: 21617128
PLOS ONE PKP2 running mouse model
PLOS ONE | https://doi.org/10.1371/journal.pone.0252649 June 4, 2021 18 / 20
31. Austin KM, Trembley MA, Chandler SF, Sanders SP, Saffitz JE, Abrams DJ, et al. Molecular mecha-
nisms of arrhythmogenic cardiomyopathy. Nat Rev Cardiol. 2019; 16(9):519–37. https://doi.org/10.
1038/s41569-019-0200-7 PMID: 31028357
32. Maron BJ, Harris KM, Thompson PD, Eichner ER, Steinberg MH. Eligibility and Disqualification Recom-
mendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell
Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
Circulation. 2015; 132(22):e343–5. https://doi.org/10.1161/CIR.0000000000000250 PMID: 26527715
33. Mazzanti A, Ng K, Faragli A, Maragna R, Chiodaroli E, Orphanou N, et al. Arrhythmogenic Right Ven-
tricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk. J Am Coll Cardiol. 2016; 68
(23):2540–50. https://doi.org/10.1016/j.jacc.2016.09.951 PMID: 27931611
34. Padron-Barthe L, Dominguez F, Garcia-Pavia P, Lara-Pezzi E. Animal models of arrhythmogenic right
ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics. Basic
Res Cardiol. 2017; 112(5):50. https://doi.org/10.1007/s00395-017-0640-3 PMID: 28688053
35. Kim JC, Perez-Hernandez M, Alvarado FJ, Maurya SR, Montnach J, Yin Y, et al. Disruption of Ca(2+)i
Homeostasis and Connexin 43 Hemichannel Function in the Right Ventricle Precedes Overt Arrhythmo-
genic Cardiomyopathy in Plakophilin-2-Deficient Mice. Circulation. 2019; 140(12):1015–30. https://doi.
org/10.1161/CIRCULATIONAHA.119.039710 PMID: 31315456
36. Cruz FM, Sanz-Rosa D, Roche-Molina M, Garcia-Prieto J, Garcia-Ruiz JM, Pizarro G, et al. Exercise
triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-
2. J Am Coll Cardiol. 2015; 65(14):1438–50. https://doi.org/10.1016/j.jacc.2015.01.045 PMID:
25857910
37. van Opbergen CJM, Noorman M, Pfenniger A, Copier JS, Vermij SH, Li Z, et al. Plakophilin-2 Haploin-
sufficiency Causes Calcium Handling Deficits and Modulates the Cardiac Response Towards Stress.
Int J Mol Sci. 2019; 20(17). https://doi.org/10.3390/ijms20174076 PMID: 31438494
38. Tester DJ, Ackerman JP, Giudicessi JR, Ackerman NC, Cerrone M, Delmar M, et al. Plakophilin-2 Trun-
cation Variants in Patients Clinically Diagnosed With Catecholaminergic Polymorphic Ventricular
Tachycardia and Decedents With Exercise-Associated Autopsy Negative Sudden Unexplained Death
in the Young. JACC Clin Electrophysiol. 2019; 5(1):120–7. https://doi.org/10.1016/j.jacep.2018.09.010
PMID: 30678776
39. Corrado D, Basso C, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden cardiac
death? J Cardiovasc Med (Hagerstown). 2006; 7(4):228–33. https://doi.org/10.2459/01.JCM.
0000219313.89633.45 PMID: 16645394
40. Potenza DM, Janicek R, Fernandez-Tenorio M, Camors E, Ramos-Mondragón R, Valdivia HH, et al.
Phosphorylation of the ryanodine receptor 2 at serine 2030 is required for a complete beta-adrenergic
response. J Gen Physiol. 2019; 151(2):131–45. https://doi.org/10.1085/jgp.201812155 PMID:
30541771
41. Wang Y, Li C, Shi L, Chen X, Cui C, Huang J, et al. Integrin β1D Deficiency-Mediated RyR2 Dysfunction
Contributes to Catecholamine-Sensitive Ventricular Tachycardia in Arrhythmogenic Right Ventricular
Cardiomyopathy. Circulation. 2020; 141(18):1477–93. https://doi.org/10.1161/CIRCULATIONAHA.
119.043504 PMID: 32122157
42. Schafers MA, Wichter T, Schafers KP, Rahman S, Rhodes CG, Lammertsma AA, et al. Pulmonary beta
adrenoceptor density in arrhythmogenic right ventricular cardiomyopathy and idiopathic tachycardia.
Basic Res Cardiol. 2001; 96(1):91–7. https://doi.org/10.1007/s003950170082 PMID: 11215537
43. Wichter T, Schafers M, Rhodes CG, Borggrefe M, Lerch H, Lammertsma AA, et al. Abnormalities of car-
diac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assess-
ment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with
positron emission tomography. Circulation. 2000; 101(13):1552–8. https://doi.org/10.1161/01.cir.101.
13.1552 PMID: 10747349
44. Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ. Altered expression of beta-adrenergic receptor
kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993; 87(2):454–63.
https://doi.org/10.1161/01.cir.87.2.454 PMID: 8381058
45. Ungerer M, Parruti G, Bohm M, Puzicha M, DeBlasi A, Erdmann E, et al. Expression of beta-arrestins
and beta-adrenergic receptor kinases in the failing human heart. Circ Res. 1994; 74(2):206–13. https://
doi.org/10.1161/01.res.74.2.206 PMID: 8293560
46. Ping P, Anzai T, Gao M, Hammond HK. Adenylyl cyclase and G protein receptor kinase expression dur-
ing development of heart failure. Am J Physiol. 1997; 273(2 Pt 2):H707–17. https://doi.org/10.1152/
ajpheart.1997.273.2.H707 PMID: 9277487
47. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, et al. Increase of
the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988; 82
(1):189–97. https://doi.org/10.1172/JCI113569 PMID: 2839545
PLOS ONE PKP2 running mouse model
PLOS ONE | https://doi.org/10.1371/journal.pone.0252649 June 4, 2021 19 / 20
48. Neumann J, Schmitz W, Scholz H, von Meyerinck L, Doring V, Kalmar P. Increase in myocardial Gi-pro-
teins in heart failure. Lancet. 1988; 2(8617):936–7. https://doi.org/10.1016/s0140-6736(88)92601-3
PMID: 2902384
49. Bohm M, Gierschik P, Jakobs KH, Pieske B, Schnabel P, Ungerer M, et al. Increase of Gi alpha in
human hearts with dilated but not ischemic cardiomyopathy. Circulation. 1990; 82(4):1249–65. https://
doi.org/10.1161/01.cir.82.4.1249 PMID: 2169357
PLOS ONE PKP2 running mouse model
PLOS ONE | https://doi.org/10.1371/journal.pone.0252649 June 4, 2021 20 / 20
